|
EFHA1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.18294304643996E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.58470047984372E-10 |
| Normal-vs-Stage2 |
1.62577999999192E-05 |
| Normal-vs-Stage3 |
2.52660004029792E-09 |
| Normal-vs-Stage4 |
2.27469999999341E-05 |
| Stage1-vs-Stage2 |
7.544200E-01 |
| Stage1-vs-Stage3 |
8.412400E-02 |
| Stage1-vs-Stage4 |
6.139200E-01 |
| Stage2-vs-Stage3 |
1.302410E-01 |
| Stage2-vs-Stage4 |
5.117200E-01 |
| Stage3-vs-Stage4 |
5.756400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.82387438485421E-12 |
| Normal-vs-AfricanAmerican |
2.79069999997716E-06 |
| Normal-vs-Asian |
4.62119999999899E-06 |
| Caucasian-vs-AfricanAmerican |
1.108200E-01 |
| Caucasian-vs-Asian |
1.628380E-01 |
| AfricanAmerican-vs-Asian |
1.325590E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.67206265394771E-12 |
| Normal-vs-Female |
1.26709998049535E-09 |
| Male-vs-Female |
8.681200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.67609999902308E-08 |
| Normal-vs-Extreme_Weight |
1.73120406898875E-11 |
| Normal-vs-Obese |
2.13980000385305E-09 |
| Normal-vs-Extreme_Obese |
1.587820E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.486600E-01 |
| Normal_Weight-vs-Obese |
9.879800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.702610E-01 |
| Extreme_Weight-vs-Obese |
8.414800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.539000E-01 |
| Obese-vs-Extreme_Obese |
2.807800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.70379999997472E-07 |
| Normal-vs-Age(41-60Yrs) |
8.5486000500623E-09 |
| Normal-vs-Age(61-80Yrs) |
1.58879576162008E-11 |
| Normal-vs-Age(81-100Yrs) |
2.83919999954918E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.519700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.646000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.801400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.243800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.696390E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.157800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.84763357128304E-12 |
| Normal-VS-Type2 PRCC |
4.19010004470977E-09 |
| Normal-VS-KIRP CIMP |
1.22829524329404E-11 |
| Normal-VS-Unclassified PRCC |
1.23200000201606E-08 |
| Type1 PRCC-VS-Type2 PRCC |
2.502600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.43310000000341E-06 |
| Type1 PRCC-VS-Unclassified PRCC |
5.112200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.96390000001468E-06 |
| Type2 PRCC-VS-Unclassified PRCC |
7.642600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.020400E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.38980005282008E-09 |
| Normal-vs-N1 |
2.12519999999161E-05 |
| Normal-vs-N2 |
3.91189999948693E-07 |
| N0-vs-N1 |
6.911800E-01 |
| N0-vs-N2 |
1.375840E-02 |
| N1-vs-N2 |
1.039380E-01 |
|
|
